CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guo Wenting, Wang Haibo, Kumar Tharkeshwar Arun, Couthouis Julien, Braems Elke, Masrori Pegah, Van Schoor Evelien, Fan Yannan, Ahuja Karan, Moisse Matthieu, Jacquemyn Maarten, Furtado Madeiro da Costa Rodrigo, Gajjar Madhavsai, Balusu Sriram, Tricot Tine, Fumagalli Laura, Hersmus Nicole, Janky Rekin's, Impens Francis, Vanden Berghe Pieter, Ho Ritchie, Thal Dietmar Rudolf, Vandenberghe Rik, Hegde Muralidhar L, Chandran Siddharthan, De Strooper Bart, Daelemans Dirk, Van Damme Philip, Van Den Bosch Ludo, Verfaillie Catherine
Аннотация
METHODS: We performed a kinome-wide CRISPR/Cas9 knock-out screen in human induced pluripotent stem cell (iPSC) -derived cortical neurons to identify modifiers of poly(PR) toxicity, and validated the role of candidate modifiers using in vitro, in vivo, and ex-vivo studies.
RESULTS: Knock-down of NIMA-related kinase 6 (NEK6) prevented neuronal toxicity caused by poly(PR). Knock-down of nek6 also ameliorated the poly(PR)-induced axonopathy in zebrafish and NEK6 was aberrantly expressed in C9orf72 patients. Suppression of NEK6 expression and NEK6 activity inhibition rescued axonal transport defects in cortical neurons from C9orf72 patient iPSCs, at least partially by reversing p53-related DNA damage.
DISCUSSION: We identified NEK6, which regulates poly(PR)-mediated p53-related DNA damage, as a novel therapeutic target for C9orf72 FTD/ALS.